001     859684
005     20210130000350.0
024 7 _ |a 10.1016/j.vascn.2018.11.005
|2 doi
024 7 _ |a 1056-8719
|2 ISSN
024 7 _ |a 1873-488X
|2 ISSN
024 7 _ |a pmid:30476620
|2 pmid
024 7 _ |a WOS:000454124000004
|2 WOS
037 _ _ |a FZJ-2019-00523
082 _ _ |a 610
100 1 _ |a Schneider, Daniela
|0 P:(DE-Juel1)156407
|b 0
|e Corresponding author
|u fzj
245 _ _ |a Influence of incubation conditions on microsomal metabolism of xanthine-derived A1 adenosine receptor ligands
260 _ _ |a New York, NY [u.a.]
|c 2019
|b Elsevier
336 7 _ |a article
|2 DRIVER
336 7 _ |a Output Types/Journal article
|2 DataCite
336 7 _ |a Journal Article
|b journal
|m journal
|0 PUB:(DE-HGF)16
|s 1554817315_28299
|2 PUB:(DE-HGF)
336 7 _ |a ARTICLE
|2 BibTeX
336 7 _ |a JOURNAL_ARTICLE
|2 ORCID
336 7 _ |a Journal Article
|0 0
|2 EndNote
520 _ _ |a Introduction:In vitro metabolism models such as liver microsomes represent an important tool for the development of novel radioligands.Comparability and physiological relevance of invitro metabolism data criticallydepend on the careful evaluation and optimization of assay protocols. We therefore investigated the influence ofincubation conditions on the microsomal stability of xanthine-derived A1 adenosine receptor (A 1AR) ligandswhich have been developed for positron emission tomography (PET).Methods:Substrate depletion assays using rat liver microsomes (RLM) were performed for three analogouscompounds which differ with regard to the metabolically vulnerable substituent at the xanthine C8 position.Incubation conditionswerevariedsystematically. Additionally, the stability of the cofactor NADPH duringing cubation was investigated.Results:Microsomal metabolism was strongly influenced by buffer pH, organic solvents and preincubation time.Substrate depletion values varied up to5-fold depending on incubation matrix composition, however, the rankorder of metabolic stability remained unchanged. Prolonged incubation periods led to drastic loss in enzymeactivity which could not be prevented by addition of metal chelators or antioxidants. Cofactor NADPH wasrapidlyoxidizedinmicrosomalmatrix,evenintheabsenceofcytochromeP450substrates.Discussion:Insummary,short incubation times, precise pH control and minimal concentrations of organic solvents are mandatory to obtain reliable microsomal stability data. Furthermore, invitro metabolic stability of thetested A 1 AR ligands varied largely depending on the particular C8 substituent. Consequently, structural modifications at the xanthine C8 position appear to be a promising strategy for the improvement of A1AR PETradioligands
536 _ _ |a 573 - Neuroimaging (POF3-573)
|0 G:(DE-HGF)POF3-573
|c POF3-573
|f POF III
|x 0
588 _ _ |a Dataset connected to CrossRef
700 1 _ |a Bier, Dirk
|0 P:(DE-Juel1)131810
|b 1
|u fzj
700 1 _ |a Bauer, Andreas
|0 P:(DE-Juel1)140200
|b 2
|u fzj
700 1 _ |a Neumaier, Bernd
|0 P:(DE-Juel1)166419
|b 3
700 1 _ |a Holschbach, Marcus
|0 P:(DE-Juel1)131824
|b 4
|u fzj
773 _ _ |a 10.1016/j.vascn.2018.11.005
|g Vol. 95, p. 16 - 26
|0 PERI:(DE-600)1491825-0
|p 16 - 26
|t Journal of pharmacological & toxicological methods
|v 95
|y 2019
|x 1056-8719
856 4 _ |u https://juser.fz-juelich.de/record/859684/files/1-s2.0-S1056871918307135-main.pdf
|y Restricted
856 4 _ |u https://juser.fz-juelich.de/record/859684/files/1-s2.0-S1056871918307135-main.pdf?subformat=pdfa
|x pdfa
|y Restricted
909 C O |p VDB
|o oai:juser.fz-juelich.de:859684
910 1 _ |a Forschungszentrum Jülich
|0 I:(DE-588b)5008462-8
|k FZJ
|b 0
|6 P:(DE-Juel1)156407
910 1 _ |a Forschungszentrum Jülich
|0 I:(DE-588b)5008462-8
|k FZJ
|b 1
|6 P:(DE-Juel1)131810
910 1 _ |a Forschungszentrum Jülich
|0 I:(DE-588b)5008462-8
|k FZJ
|b 2
|6 P:(DE-Juel1)140200
910 1 _ |a Forschungszentrum Jülich
|0 I:(DE-588b)5008462-8
|k FZJ
|b 3
|6 P:(DE-Juel1)166419
910 1 _ |a Forschungszentrum Jülich
|0 I:(DE-588b)5008462-8
|k FZJ
|b 4
|6 P:(DE-Juel1)131824
913 1 _ |a DE-HGF
|b Key Technologies
|l Decoding the Human Brain
|1 G:(DE-HGF)POF3-570
|0 G:(DE-HGF)POF3-573
|2 G:(DE-HGF)POF3-500
|v Neuroimaging
|x 0
|4 G:(DE-HGF)POF
|3 G:(DE-HGF)POF3
914 1 _ |y 2019
915 _ _ |a Nationallizenz
|0 StatID:(DE-HGF)0420
|2 StatID
915 _ _ |a JCR
|0 StatID:(DE-HGF)0100
|2 StatID
|b J PHARMACOL TOX MET : 2017
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0200
|2 StatID
|b SCOPUS
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0300
|2 StatID
|b Medline
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0310
|2 StatID
|b NCBI Molecular Biology Database
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0600
|2 StatID
|b Ebsco Academic Search
915 _ _ |a Peer Review
|0 StatID:(DE-HGF)0030
|2 StatID
|b ASC
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0199
|2 StatID
|b Clarivate Analytics Master Journal List
915 _ _ |a WoS
|0 StatID:(DE-HGF)0111
|2 StatID
|b Science Citation Index Expanded
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0150
|2 StatID
|b Web of Science Core Collection
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1050
|2 StatID
|b BIOSIS Previews
915 _ _ |a IF < 5
|0 StatID:(DE-HGF)9900
|2 StatID
920 _ _ |l yes
920 1 _ |0 I:(DE-Juel1)INM-5-20090406
|k INM-5
|l Nuklearchemie
|x 0
920 1 _ |0 I:(DE-Juel1)INM-2-20090406
|k INM-2
|l Molekulare Organisation des Gehirns
|x 1
980 _ _ |a journal
980 _ _ |a VDB
980 _ _ |a I:(DE-Juel1)INM-5-20090406
980 _ _ |a I:(DE-Juel1)INM-2-20090406
980 _ _ |a UNRESTRICTED


LibraryCollectionCLSMajorCLSMinorLanguageAuthor
Marc 21